Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
HRTX | US
0.07
3.59%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
19/09/2024
2.02
1.99
2.11
1.95
Heron Therapeutics Inc. a biotechnology company engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer a drug delivery technology which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron) an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI an intravenous formulation of aprepitant a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; HTX-019 an investigational agent for the prevention of postoperative nausea and vomiting; and HTX-034 for postoperative pain management as well as is in Phase Ib/II clinical study in patients undergoing bunionectomy. The company was formerly known as A.P. Pharma Inc. and changed its name to Heron Therapeutics Inc. in January 2014. Heron Therapeutics Inc. was founded in 1983 and is headquartered in San Diego California.
View LessStrength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
28.3%1 month
56.0%3 months
91.4%6 months
81.7%-
-
12.60
-4.71
0.82
-1.55
2.90
-0.18
-26.02M
306.37M
306.37M
-
-17.89
-
13.40
-2.41K
14.20
30.62
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.38
Range1M
0.41
Range3M
2.02
Rel. volume
1.62
Price X volume
5.33M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Aurora Cannabis Inc | ACB | Drug Manufacturers-Specialty & Generic | 5.77 | 315.39M | -1.37% | n/a | 0.00% |
Solid Biosciences Inc | SLDB | Drug Manufacturers-Specialty & Generic | 8 | 308.76M | 12.04% | n/a | 13.09% |
ESSA Pharma Inc | EPIX | Drug Manufacturers-Specialty & Generic | 6.48 | 287.51M | 7.11% | n/a | 0.27% |
Cipher Pharmaceuticals Inc | CPHRF | Drug Manufacturers-Specialty & Generic | 11.03 | 284.72M | -3.50% | 12.74 | 0.00% |
Alpha Teknova Inc. Common Stock | TKNO | Drug Manufacturers-Specialty & Generic | 5.11 | 272.38M | 2.00% | n/a | 39.24% |
Procaps Group S.A. Ordinary Shares | PROC | Drug Manufacturers-Specialty & Generic | 1.8 | 203.08M | -0.55% | 3.63 | 0.00% |
Galectin Therapeutics Inc | GALT | Drug Manufacturers-Specialty & Generic | 2.84 | 176.87M | 4.80% | n/a | -113.78% |
LFCR | LFCR | Drug Manufacturers-Specialty & Generic | 5.62 | 173.65M | 8.08% | 20.72 | 241.85% |
CRDL | CRDL | Drug Manufacturers-Specialty & Generic | 2.25 | 157.36M | 2.27% | n/a | 1.07% |
Zomedica Pharmaceuticals Corp | ZOM | Drug Manufacturers-Specialty & Generic | 0.13 | 129.73M | 1.96% | n/a | 1.10% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
CPI Card Group Inc | PMTS | Building Products & Equipment | 29.35 | 324.79M | 14.20% | 16.56 | -621.78% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 18.35 | 304.85M | 2.23% | 35.51 | 26.82% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.5 | 236.20M | -2.49% | 9.50 | 39.79% |
Unifi Inc | UFI | Textile Manufacturing | 7.59 | 138.98M | 6.60% | n/a | 52.56% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 37.9 | 107.64M | -1.76% | 5.90 | 15.58% |
Culp Inc | CULP | Textile Manufacturing | 6.35 | 79.31M | 5.31% | n/a | 11.29% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 5.78 | 62.58M | -6.47% | n/a | 54.96% |
ILAG | ILAG | Building Products & Equipment | 1.04 | 18.78M | 13.06% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.02 | 12.43M | -7.27% | n/a | 16.03% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.737 | 11.34M | 3.80% | n/a | 422.08% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -1.55 | - | Cheaper |
Ent. to Revenue | 2.90 | - | Cheaper |
PE Ratio | - | 29.14 | - |
Price to Book | 12.60 | 12.81 | Par |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 91.36 | - | Riskier |
Debt to Equity | -4.71 | -0.93 | Cheaper |
Debt to Assets | 0.82 | 0.45 | Expensive |
Market Cap | 306.37M | - | Emerging |